Dolutegravir Pharmacokinetics During Weekly Rifapentine/Isoniazid for TB Prevention

Clinical trial NCT06281834 · RECRUITING

Trial details

NCT number: NCT06281834
Sponsor: Brigham and Women's Hospital
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Pediatric HIV Infection Latent Tuberculosis

Start date: 2024-11-15
Primary completion: 2027-02-01
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.